“…EMA and PMA have since their invention been applied to a wide variety of microorganisms including bacterial vegetative cells (Agusti et al, 2010;Bae and Wuertz, 2009;Cawthorn and Witthuhn, 2008;Delgado Viscogliosi et al, 2009;Pan and Breidt, 2007;Rudi et al, 2005a;Soejima et al, 2007), bacterial spores (Rawsthorne et al, 2009), fungi (Vesper et al, 2008), viruses Graiver et al, 2010;Sanchez et al, 2012), yeast (Andorrà et al, 2010;Shi et al, 2012), and protozoa (Brescia et al, 2009;Fittipaldi et al, 2011a). The addition of a pre-treatment step to the sample analysis to inhibit the amplification of DNA from membrane-damaged cells has been used in combination with end point PCR (Brescia et al, 2009), real-time or quantitative PCR (qPCR) (Rudi et al, 2005a), reverse transcription PCR (Graiver et al, 2010), isothermal amplification Lu et al, 2009;Wang et al, 2012), denaturing gradient gel electrophoresis (DGGE) (Nocker et al, 2007a), terminal restriction fragment length polymorphism (TRFLP) (Rogers et al, 2008), microarray technology , and nextgeneration sequencing .…”